CKD (Chronic Kidney Disease) Stage 5D
12
6
6
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
8%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (12)
Effect of Canagliflozin on Ultrafiltration & Fibrosis in Patients on Peritoneal Dialysis
Tubeless Spontaneous Ventilation Anesthesia in Kidney Transplantation
Incidence and Prognostic of Cardiac Surgery-Associated Acute Kidney Injury: A Spanish Multicenter Study (SCARS-AKI)
Studies on Adsorption International Learning Initiative Global
ASPIrin in Reducing Events in Dialysis ( ASPIRED )
The Effect of Exercise on Blood Pressure Variability on Peritoneal Dialysis Patients
Effect of Kidney Replacement Therapy with Polymethylmethacrylate Membranes on Pruritus-related Quality of Life in Patients Receiving Maintenance Haemodialysis
Impact of Propionic Acid on Regulatory T Cell Function in Children With CKD
Duration of Protection From Pneumonia After Pneumococcal Vaccination in Hemodialysis Patients
Genetics in the Progression of Nephropathies
Impact of CKD on Children and Their Families
NGAL and Hepcidin Levels in Hemodialysis Patients in Assiut University Hospital